BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11224218)

  • 1. U-50, 488, saline and naltrexone discrimination in U-50, 488-treated pigeons.
    France CP; Woods JH
    Behav Pharmacol; 1993 Oct; 4(5):509-516. PubMed ID: 11224218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine, saline and naltrexone discrimination in morphine-treated pigeons.
    France CP; Woods JH
    J Pharmacol Exp Ther; 1987 Jul; 242(1):195-202. PubMed ID: 3612524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of opioids in morphine-treated pigeons trained to discriminate among morphine, the low-efficacy agonist nalbuphine, and saline.
    Walker EA; Picker MJ; Granger A; Dykstra LA
    J Pharmacol Exp Ther; 2004 Jul; 310(1):150-8. PubMed ID: 15044559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus effects of opioid agonists in morphine-dependent pigeons.
    France CP; Woods JH
    J Pharmacol Exp Ther; 1990 Aug; 254(2):626-32. PubMed ID: 2384889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus effects on enadoline in pigeons.
    Brandt MR; France CP
    J Pharmacol Exp Ther; 1996 May; 277(2):960-7. PubMed ID: 8627579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opiate agonist-antagonist interactions: application of a three-key drug discrimination procedure.
    France CP; Woods JH
    J Pharmacol Exp Ther; 1985 Jul; 234(1):81-9. PubMed ID: 4009506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative stimulus effects of naltrexone in morphine-treated rhesus monkeys.
    France CP; Woods JH
    J Pharmacol Exp Ther; 1989 Sep; 250(3):937-43. PubMed ID: 2550623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic l-alpha acetylmethadol in rhesus monkeys: discriminative stimulus and other behavioral measures of dependence and withdrawal.
    Brandt MR; France CP
    J Pharmacol Exp Ther; 1998 Dec; 287(3):1029-37. PubMed ID: 9864289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute supersensitivity to the discriminative stimulus effects of naltrexone in pigeons.
    France CP; Woods JH
    J Pharmacol Exp Ther; 1988 Feb; 244(2):599-605. PubMed ID: 3346837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative-stimulus control by morphine in the pigeon under a fixed-interval schedule of reinforcement.
    Massey BW; McMillan DE; Wessinger WD
    Behav Pharmacol; 1992 Oct; 3(5):475-488. PubMed ID: 11224150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence.
    Holtzman SG
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1033-41. PubMed ID: 12604679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the discriminative stimulus effects of buprenorphine in pigeons.
    Galici R; Brandt MR; France CP
    Psychopharmacology (Berl); 2002 Mar; 160(2):132-9. PubMed ID: 11875630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey: a further characterization.
    White DA; Holtzman SG
    J Pharmacol Exp Ther; 2005 Jul; 314(1):374-82. PubMed ID: 15843500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in sensitivity to the rate-decreasing effects of opioids in pigeons treated acutely or chronically with nalbuphine.
    Gerak LR; France CP
    Behav Pharmacol; 1996 Oct; 7(5):437-447. PubMed ID: 11224439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative efficacy of buprenorphine, nalbuphine and morphine in opioid-treated rhesus monkeys discriminating naltrexone.
    Sell SL; McMahon LR; France CP
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1167-73. PubMed ID: 12766254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and chronic effects of naltrexone and naloxone on schedule-controlled behavior of squirrel monkeys and pigeons.
    Goldberg SR; Morse WH; Goldberg DM
    J Pharmacol Exp Ther; 1981 Mar; 216(3):500-9. PubMed ID: 7205630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative stimulus effects of reversible and irreversible opiate agonists: morphine, oxymorphazone and buprenorphine.
    France CP; Jacobson AE; Woods JH
    J Pharmacol Exp Ther; 1984 Sep; 230(3):652-7. PubMed ID: 6206224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminative stimulus properties of (+)- and (-)-n allylnormetazocine: the role of training dose in the stimulus substitution patterns produced by PCP/sigma and mixed action opioid compounds.
    Picker MJ
    Behav Pharmacol; 1991 Dec; 2(6):497-511. PubMed ID: 11224092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus effects of dextrorphan in pigeons.
    Herling S; Solomon RE; Woods JH
    J Pharmacol Exp Ther; 1983 Dec; 227(3):723-31. PubMed ID: 6655565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrimination among morphine, saline and naltrexone in rhesus monkeys receiving morphine subchronically.
    France CP
    Behav Pharmacol; 1994 Feb; 5(1):15-20. PubMed ID: 11224247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.